A combination of artemisinin, moxidectin, and doxorubicin drugs can selectively and efficiently induce apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo
Viviana Soto-Mercado, Miguel Mendivil-Perez, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo · 2026
Read A combination of artemisinin, moxidectin, and doxorubicin drugs can selectively and efficiently induce apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo by Viviana Soto-Mercado, Miguel Mendivil-Perez, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13400675.txt.
Description
Viviana Soto-Mercado and colleagues test, in 2026, a three-drug mix meant to push leukemia cells into programmed death. Two leukemia types, acute lymphoblastic and chronic myeloid, often resist treatment by dodging that death program. Searching combinations of three or more drugs is complex, so the team built a stepwise dosing method.
Eight candidate drugs were first screened on a leukemia cell line across several death-related readouts. The winning trio combined an antimalarial, artemisinin, an antiparasitic, moxidectin, and a chemotherapy drug, doxorubicin, each at half its individual effective dose. Together they stalled the cell cycle, collapsed cell power stations and switched on death enzymes in two cell lines and in patient cells grown outside the body, while sparing non-leukemic cells.
Catalog record
| CREATOR | Viviana Soto-Mercado, Miguel Mendivil-Perez, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63499 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |